Overall, our data does not contradict current international guidelines from KDIGO, where PAC is suggested for NS patients with low risk of bleeding and S-albumin <20–25g/L, especially for patients with membranous nephropathy [16]. The gene discussed is ALB; the disease is membranous glomerulonephritis.